In addition to MEK/ERK and PKC inhibitors, calcium channel blockers, calmodulin inhibitors, NO donors, and agents that restrict actin polymerization have anti-influenza effects [15], [16], [17], [18]. This evidence concerns the gene MAPK1 and influenza.